Cinven, an international private equity firm, agreed to acquire a majority stake in Barentz, a Dutch company specializing in the production of ingredients for the pharmaceutical, cosmetics and food industries. Financial terms were not disclosed. "We are delighted to be working with Cinven on the next phase of our growth. In particular, their investment and support for our business strategy will enable us to expand our operations into new geographic markets, including through acquisition, and will ensure we have the right infrastructure to achieve this," Hidde van der Wal, Barentz CEO.